Grifols (GRFS) Interest Coverage Ratio (2010 - 2018)
Grifols (GRFS) reported Interest Coverage Ratio of 3.67 for Q2 2018, down 10.55% on a YoY basis from 4.1 in Q2 2017, and down 91.44% quarter-over-quarter from 42.9 in Q4 2017.
Grifols (GRFS) Interest Coverage Ratio (2010 - 2018) Analysis & Trends
Grifols has reported Interest Coverage Ratio for 8 years, with the latest figure at 3.67 in Q2 2018.
- For the quarter ending Q2 2018, Interest Coverage Ratio fell 10.55% year-over-year to 3.67; the trailing twelve-month figure through Mar 2020 stood at 1.2527028178385691e+17 (down 2.5599051633920134e+17% YoY), and the FY2025 full-year result was 1.99, up 19.13% from the prior year.
- Interest Coverage Ratio for Q2 2018 stood at 3.67, down from 42.9 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 42.9 in Q4 2017, with the low at 3.66 in Q1 2016.
- Historically, Interest Coverage Ratio has averaged 7.15 across 4 years, with a median of 3.91 in 2016.
- Annual changes were most pronounced in 2016 — Interest Coverage Ratio tumbled 194.11% — and 2017, when it surged 1653.03%.
- Grifols' Interest Coverage Ratio stood at 14.86 in 2015, then plunged by 118.59% to 2.76 in 2016, then surged by 1653.03% to 42.9 in 2017, then tumbled by 91.44% to 3.67 in 2018.
- The last three Interest Coverage Ratio figures came in at 3.67 (Q2 2018), 42.9 (Q4 2017), and 4.1 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Grifols | 6.05 Bn | 5.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 3.67 |
| Dec 31, 2017 | 42.90 |
| Jun 30, 2017 | 4.10 |
| Dec 31, 2016 | -2.76 |
| Sep 30, 2016 | 3.91 |
| Jun 30, 2016 | 3.64 |
| Mar 31, 2016 | -3.66 |
| Dec 31, 2015 | 14.86 |
| Sep 30, 2015 | 4.09 |
| Jun 30, 2015 | 4.00 |
| Mar 31, 2015 | 3.89 |
| Sep 30, 2013 | 3.21 |
| Jun 30, 2013 | 3.05 |
| Mar 31, 2013 | 3.18 |
| Dec 31, 2012 | 5.24 |
| Sep 30, 2012 | 2.39 |
| Jun 30, 2012 | 2.47 |
| Mar 31, 2012 | 2.10 |
| Dec 31, 2011 | -1.76 |
| Sep 30, 2011 | 1.69 |